Skip to main content
Humedix Co., Ltd. logo

Humedix Co., Ltd. — Investor Relations & Filings

Ticker · 200670 ISIN · KR7200670008 KO Manufacturing
Filings indexed 317 across all filing types
Latest filing 2022-11-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 200670

Humedix Co., Ltd. is a healthcare company that develops and manufactures biological and pharmaceutical products focused on human health and beauty. The company specializes in hyaluronic acid-based applications, producing medical devices such as dermal fillers and arthritis treatments. Its portfolio also includes prescription medicines, active pharmaceutical ingredients (APIs), and functional cosmetics. Additionally, Humedix offers Contract Manufacturing Organization (CMO) services within the healthcare sector.

Recent filings

Filing Released Lang Actions
분기보고서 (2022.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Humedix' (주식회사 휴메딕스) covering the period from January 1, 2022, to September 30, 2022. It contains detailed financial information, business operations, and management discussions, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2022
2022-11-14 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (Non-Deal Roadshow and Conference call). It provides details such as the date, location, target audience, and purpose of the meeting. Since it is an announcement of an event rather than the presentation materials themselves, and it serves as a regulatory notification of corporate activity, it fits best under the 'Regulatory Filings' category as a general announcement.
2022-10-25 Korean
전환가액의조정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from Humedix regarding the adjustment of the conversion price of convertible bonds due to a decline in market price. This type of disclosure relates to changes in capital structure and financial instruments. Since it specifically details the adjustment of conversion prices for existing debt, it falls under the 'Capital/Financing Update' category.
2022-10-06 Korean
주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Korean financial authorities regarding a decision to enter into a trust agreement for the acquisition of treasury shares (자기주식취득 신탁계약 체결 결정). This is a specific corporate action involving the company's own shares. According to the provided definitions, 'Transaction in Own Shares' (POS) covers reports of the company buying back or selling its own shares, which aligns perfectly with the content of this filing.
2022-09-27 Korean
신탁계약해지결과보고서
Transaction in Own Shares Classification · 100% confidence The document is a '신탁계약해지결과보고서' (Report on the Termination of a Trust Agreement) filed by Humedix with the Financial Supervisory Service (FSS). It details the termination of a stock repurchase trust contract and the subsequent transfer of the acquired treasury shares to the company's own account. This falls under the category of share buyback/repurchase reporting, which is classified as 'Transaction in Own Shares' (POS).
2022-09-16 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding the scheduling and logistics of an Investor Relations (IR) event (a Non-Deal Roadshow and conference call). It provides the date, location, purpose, and contact information for the event. Since it is an announcement of an upcoming presentation rather than the presentation materials themselves, and it does not fit into specific categories like earnings releases or financial reports, it is classified as a regulatory filing announcement.
2022-08-22 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.